Contrary to arguments oft-used by opponents of marijuana and marijuana law reform, “cannabis use does not significantly compound the gray matter deficits associated with schizophrenia”.
This is according to a study published by the journal Psychiatry Research: Neuroimaging, and conducted by researchers at Vanderbilt University Medical Center in Tennessee.
The study’s abstract starts by stating that; “Substance use may confound the study of brain structure in schizophrenia. We used voxel-based morphometry (VBM) to examine whether differences in regional gray matter volumes exist between schizophrenia patients with and without clinically significant cannabis and/or alcohol use histories compared to 88 healthy control subjects.”
Read moreMarijuana Use Doesn’t Lead to Deficits Associated With Schizophrenia, Finds Study